Entrectinib
Specifications
1108743-60-7CAS Number
816-298-8EC Number
N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamideIUPAC Name
C31H34F2N6O2Chemical Formula
560.6 g/molMolecular Weight
Entrectinib; 1108743-60-7; Rozlytrek; RXDX-101; NMS-E628; entrectinibum; L5ORF0AN1I; RXDX 101; N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide; DTXSID101026450; Benzamide, N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-((tetrahydro-2H-pyran-4-yl)amino)-; N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide; N-{5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide; Benzamide, N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-; N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide; RXDX101; N-(5-((3,5-Difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((oxan-4-yl)amino)benzamide; N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide; RefChem:58006; L01XE56; DTXCID101510637; Entrectinib (RXDX-101); N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide; N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide; MFCD28129099; Entrectinib(rxdx-101); N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydropyran-4-ylamino)benzamide; Entrectinib [INN]; UNII-L5ORF0AN1I; Entrectinib [USAN:INN]; C31H34F2N6O2; Rozlytrek (TN); N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide; N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide; YMX; Entrectinib, 95%; RG 6268; Entrectinib (Standard); Kinome_2659; ENTRECTINIB [MI]; ENTRECTINIB [JAN]; Entrectinib; NMS-E628; ENTRECTINIB [USAN]; ENTRECTINIB [WHO-DD]; Entrectinib (RXDX-101)?; Entrectinib (JAN/USAN/INN); GTPL8290; orb1226975; orb1303916; SCHEMBL3512601; CHEMBL1983268; SCHEMBL29358922; SCHEMBL29394152; NMS-E 628; ENTRECTINIB [ORANGE BOOK]; CHEBI:195558; HAYYBYPASCDWEQ-UHFFFAOYSA-N; NMS-E628;RXDX-101; GLXC-90362; HMS3886H21; HMS5086A05; EX-A2261; EBC-17153; HY-12678R; NSC774769; NSC800095; RG6268; s7998; AKOS030632786; CCG-270048; DB11986; NSC-774769; NSC-800095; RG-6268; SB17194; NCGC00484067-01; NCGC00484067-02; NCGC00484067-03; NCGC00484067-04; AC-31286; AS-75092; BP-43651; DA-47850; HY-12678; N4974; NS00072566; D10926; EN300-7376549; F862509; BRD-K39009484-001-01-4; Q25323953; N-[5-(3,5-Difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide; N-[5-[[3,5-bis(fluoranyl)phenyl]methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide; N-{5-[(3,5-difluorophenyl)methyl]-3H-indazol-3-ylidene}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamideSynonyms
